Godavari Drugs Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,532 shares,. Its Average Traded Price (ATP) is ₹115.90, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹118.95.
Godavari Drugs has an upper circuit limit of ₹140.30 and a lower circuit limit of ₹93.60. The total value traded stands at ₹1.78 L, and the delivery percentage for the day is 88.16%.
The stock is currently traded with a market lot size of 1. Godavari Drugs also offers a dividend yield of 0%.
Godavari Drugs Share Price Chart
Godavari Drugs Share Key Metrics
Volume
1532.00
Market Cap
135.14 CR
LTQ@LTP
2@118.95
ATP
115.9
Var Margin
25.55 %
Circuit Range
93.6-140.3
Delivery %
88.16 %
Value
1.78 L
ASM/GSM
No
Market Lot
1
Godavari Drugs Resistance and Support
Pivot 117.62
Resistance
First Resistance
119.34
Second Resistance
121.72
Third Resistance
123.44
Support
First Support
115.24
Second Support
113.52
Third Support
111.14
Godavari Drugs Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Godavari Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-11 | Quarterly Results |
| 2026-08-14 | Quarterly Results |
| 2026-05-27 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2026-01-15 | Preferential issue of shares |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results & A.G.M. |
| 2025-05-29 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Godavari Drugs News
Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Sushma Kakani has converted 1.41 lakh warrants into equity shares, acquiring a 1.20% additional voting right. Her total holding in Godavari Drugs has subsequently increased from 11.87% to 12.28%.
Nov 18 2026 11:47:51
Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Mohit Jaju acquired 1,33,355 equity shares of Godavari Drugs via conversion of warrants. His shareholding increased from 6.12% to 6.85% following the allotment.
Nov 17 2026 17:51:19
Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Mukund Kakani acquired 1,56,334 equity shares in Godavari Drugs upon conversion of warrants. His shareholding increased from 4.64% to 5.66%.
Nov 17 2026 16:39:04
Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Aksheit Kakani acquired 50,000 equity shares of Godavari Drugs upon the conversion of 50,000 convertible warrants. Following this allotment, his voting shareholding increased from 3.45% to 3.64%.
Nov 17 2026 16:37:16
Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Godavari Drugs promoter Tanushree Kakani converted 46,000 warrants into equity shares. Post-conversion, her stake in the company has increased from 1.70% to 1.98%.
Nov 17 2026 16:35:40
Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Kamala Jaju converted 1,00,000 warrants into equity shares, increasing her stake from 9.25% to 9.49%. She still holds 1,00,000 convertible warrants for future conversion.
Nov 17 2026 16:29:18
Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Ghanshyam Jaju acquired 60,000 equity shares representing a 0.51% stake via the conversion of warrants. His total holding in the company has now increased to 4.02%.
Nov 17 2026 16:27:52
Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Godavari Drugs promoter Priyanka Jaju converted 33,334 warrants into equity shares on 17 Nov 2026. Her equity stake in the company has increased to 2.15%, while her total holding remains unchanged at 2.28%.
Nov 17 2026 16:24:51
Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Ieshir Jaju has converted 66,667 warrants into equity shares of Godavari Drugs for Rs.44.5 lakh. Following this allotment, the promoter's equity holding increases from 0.61% to 1.14%.
Nov 17 2026 16:23:41
Godavari Drugs Ltd - 530317 - Board Meeting Outcome for Outcome For The Board Meeting Held On 11/11/2026
Godavari Drugs reported its Q2 FY27 financial results with revenue of ₹28.23 crores and net profit of ₹0.96 crores. The board also confirmed there is no deviation in the utilization of the preferential issue proceeds for the quarter.
Nov 11 2026 17:14:37
Godavari Drugs Management
| Name | Position |
|---|---|
| Venkatesh Achanta | Company Secretary & Compliance Officer |
| Ghanshyam Jaju | Chairman |
Godavari Drugs Similar Stocks
Cian Healthcare Ltd.
44.10
0.86 (1.99%)
Star Imaging and Path Lab Ltd.
58.00
0.00 (0.00%)
Everest Organics Ltd.
219.40
-0.10 (0.05%)
Concord Drugs Ltd.
68.87
-0.92 (1.32%)
Kretto Syscon Ltd.
0.39
0.00 (0.00%)
Vasundhara Rasayans Ltd.
117.95
-2.80 (2.32%)
Pharmaids Pharmaceuticals Ltd.
21.26
0.73 (3.56%)
Modern Diagnostic & Research Centre Ltd.
53.01
0.49 (0.93%)
Godavari Drugs FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GODAVARI
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC